Search

everythinglearnresearchcommunity

for

Search:↓

Most women with excessive hair growth have PCOS; treatment varies and focuses on preventing new hair, with electrolysis as the only permanent removal method.

Some men with early hair loss may have a male version of PCOS, affecting hormones and increasing health risks.

New signs like changes in blood markers, physical symptoms, and behavioral shifts may help detect hidden steroid use in athletes.

Finasteride use can cause lasting negative effects like sexual dysfunction, depression, anxiety, and cognitive issues.

Longer GGN repeats in the androgen receptor gene are linked to polycystic ovary syndrome.

Knuckle Acanthosis Nigricans is common in Latin American youth and may indicate early insulin resistance, especially in those with normal weight.

Young women with PCOS and no other heart risk factors have normal heart function.

Finasteride reduces testosterone conversion, progesterone lessens this, and levamisole enhances finasteride's effect.

Topical minoxidil is the most promising treatment for male pattern hair loss, but more research is needed to confirm its effectiveness and safety.

Normal-range ALT levels can indicate metabolic and hormonal imbalances in young women.

The medication combination did not affect glucose tolerance but increased some cholesterol levels due to its estrogen component.

Some alopecia treatments might help treat COVID-19, but more research is needed.

Scalp cooling devices need to be powerful enough to overcome heat loss and reach the right temperature to prevent hair loss from chemotherapy.

The mini-lift is a less invasive face-lift for younger patients that is quicker, cheaper, and has a fast recovery, but is less effective for the midface and excessive neck skin.

Most people in Turkey start getting gray hair around 33 years old, with factors like age, education, hair loss, skin type, family history, and anxiety playing a role.

Testosterone replacement therapy improved blood sugar and fat levels without raising prostate cancer risk in Japanese men with low testosterone.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Using hair dye may slightly increase the risk of non-Hodgkin's lymphoma, especially with long-term use.

The woman's high testosterone levels indicated PCOS, leading to treatment that improved her symptoms.

Vitamin D may help reduce antibody levels in men with autoimmune thyroiditis and early-onset androgenic alopecia, but has no significant impact on thyroid function.

Policosanol helps treat hair loss by balancing hormones and supporting hair growth.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

Premature hair greying may indicate a higher risk of metabolic problems.

The document concludes that diagnosing PCOS requires a thorough approach, considering various symptoms and risks, and calls for improved methods to identify PCOS types and prevent diabetes.

Male yak hair growth is influenced by DHT synthesis, which is promoted by 5α-red1 and AR during growth phases, while E2 may inhibit growth through ERα.

Hair loss is linked to insulin resistance in women, regardless of hormone levels.

Different types of polycystic ovary syndrome show varying levels of insulin resistance, with the 'PHO' type being the most insulin resistant.

Women with irregular periods have a higher risk of heart disease.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Women with PCOS tend to be less optimistic than those without it.